Increased use of drug-eluting stents, ICDs nets higher costs for patients

May 20, 2010

Increased use of drug-eluting stents (DES) and implantable cardioverter-defibrillators (ICDs) between 2003 and 2006 netted significantly higher costs for coronary artery disease and chronic heart failure patients, researchers said.

The increased use of these technologies also partly explained the growth in healthcare costs during these years.

DES and ICDs are among the most common and costly interventional therapies used in patients with cardiovascular disease.

In the study, researchers looked at the fiscal impact of these devices by examining Medicare claims from 2003 to 2006 and separately identifying groups of patients between ages 66 and 85 in each year diagnosed with coronary artery disease and chronic . They calculated annual average cost of care, as well as the average use rate of DES for coronary artery disease and ICDs for chronic heart failure.

The researchers found:

  • The average inflation-adjusted costs for coronary artery disease patients increased from $12,160 in 2003 to $12,721 in 2006.
  • The average costs for chronic heart failure patients increased from $17,153 in 2003 to $18,371 in 2006.
  • The average cost increase for coronary artery disease patients treated with DES was $412, while the average cost increase for chronic heart failure patients with ICDs was $189.
As a result, between 2003 and 2006, the total cost increase attributable to DES in the Medicare population ages 66 to 85 was $3.32 billion (73 percent of total growth). The total cost increase in the Medicare chronic heart failure population attributable to ICDs was $774 million (15 percent of total growth).

Explore further: Ebola expert calls for European anti-virus 'corps'

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Ebola expert calls for European anti-virus 'corps'

Dec 26, 2014

Europe will be "vulnerable" if it does not regard viruses as a "national security issue" like the United States, the microbiologist who discovered Ebola said in an interview published Friday.

In Liberia, Ebola steals Christmas

Dec 26, 2014

The Ebola epidemic has cast a dark shadow over Christmas this year in Liberia, where small businesses are especially feeling the pinch.

Firm recalls caramel apples amid listeria fears

Dec 25, 2014

A Missouri firm is recalling its Happy Apple brand caramel apples because of the potential that they could be contaminated with listeria. The recall comes after at least three deaths and at least 29 illnesses in 10 states ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.